Company / Working Capital
OCULAR THERAPEUTIX, INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$731.3M
FY2025
5-year range
$98.2M / $731.3M
FY2021-FY2025
Trend
+83.0%
vs FY2024
Sector context
#59 of 213
Health Care
What the data says
At $731M, OCULAR THERAPEUTIX, INC's working capital ranks #59 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $98M in FY2022 to $731M in FY2025.
Based on SEC 10-K filings.
$731M in FY2025 with a 5-year CAGR of +27.2%.
Improved from $197M to $731M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +95.3%
- 5-Year CAGR
- +27.2%
- 10-Year CAGR
- -
Sector benchmark
#59 of 213 in Health CareTop 28% of 213This company $731.3M Sector average $934.6M
▼
-21.7% below sector average
Key checks
Key Insights
- OCULAR THERAPEUTIX, INC's working capital has grown for 3 consecutive years.
- 5-year CAGR of +27.2%, indicating consistent growth.
- In FY2025, working capital increased 83.0% year-over-year.
- Ranks #59 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $731.3M | +83.0% |
| FY2024 | $399.6M | +102.5% |
| FY2023 | $197.3M | +100.9% |
| FY2022 | $98.2M | -40.5% |
| FY2021 | $165.0M | -24.8% |
| FY2020 | $219.5M | +355.9% |
| FY2019 | $48.1M | +2.4% |
| FY2018 | $47.0M | +57.2% |
| FY2017 | $29.9M | -51.4% |
| FY2016 | $61.6M | -39.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026